Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T09:05:33.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-01T05:57:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-07-25T01:16:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The service alert has been updated to reflect a planned maintenance period starting on July 25th, with services expected to be unavailable for over 24 hours, compared to the previous alert which indicated maintenance starting on July 26th for 12+ hours.
    Difference
    0.3%
    Check dated 2025-07-17T20:38:28.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.
    Difference
    0.7%
    Check dated 2025-07-10T16:43:52.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    0.8%
    Check dated 2025-07-03T12:39:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.